세계의 일회용 내시경 시장 : 유형별, 임상 사용별, 용도별, 최종 사용자별, 지역별 예측

The global disposable endoscopes market is projected to reach USD 2.67 billion by 2030, growing from USD 0.95 billion in 2025, at a CAGR of 22.9% from 2025 to 2030.

The disposable endoscopes market is experiencing strong growth driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and ongoing advancements in imaging and optical technologies. Emerging markets offer substantial opportunities due to improving healthcare infrastructure, expanding procedure volumes, and the growth of medical tourism, which facilitate the wider adoption of advanced endoscopic solutions. However, market growth faces challenges such as infection risks, insufficient sterilization and reprocessing practices, and high procedural costs, which may limit broader adoption-particularly in cost-sensitive and resource-limited healthcare settings.

The bronchoscopes segment accounted for the second-largest growth in the disposable endoscopes market in 2024.

By type, the disposable endoscopes market is divided into urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, and other disposable endoscopes. Among these, the bronchoscopes segment held the second-largest market share in 2024, driven by the increasing global incidence of respiratory diseases, especially lung cancer. According to the American Cancer Society, in 2025, the US is expected to see about 226,650 new lung cancer cases and 124,730 related deaths, while the World Cancer Research Fund reported 2,480,675 new cases worldwide in 2022. This rising disease burden has significantly boosted the demand for bronchoscopy procedures for early diagnosis and treatment. Disposable bronchoscopes are increasingly chosen because they help prevent cross-contamination, eliminate the need for reprocessing, and ensure consistent performance in emergency and intensive care situations. Additionally, advancements in imaging technology and maneuverability, along with growing adoption by hospitals and outpatient clinics, are further driving the growth of this segment, making bronchoscopes the second largest contributor to the disposable endoscopes market.

The surgical segment accounted for the largest share of the disposable endoscopes market in 2024.

By clinical practice, the disposable endoscopes market is divided into diagnostic and surgical uses. In 2024, the surgical use segment held the largest market share. This growth is driven by the rising adoption of minimally invasive surgical procedures across various specialties, including gastroenterology, urology, pulmonology, and gynecology. Surgeons favor disposable endoscopes for their superior sterility, reliable performance, and ability to eliminate risks associated with cross-contamination and reprocessing errors. The increasing prevalence of chronic conditions such as cancer, kidney disorders, and respiratory diseases has led to a rise in surgical procedures that require precise visualization and dependable instrumentation. Additionally, the availability of advanced single-use endoscopes with high-definition imaging and ergonomic designs improves procedural efficiency and safety. Hospitals and outpatient surgical centers are increasingly shifting toward single-use devices to enhance infection control and streamline operations. Collectively, these factors establish the surgical usage segment as the leading contributor to the disposable endoscopes market by clinical application.

Europe accounted for the second-largest position in the disposable endoscopes market during the forecast period.

The global disposable endoscopes market is divided into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe held the second-largest share in this market. This is due to a mix of demographic trends, high disease rates, and advanced healthcare systems. The region is experiencing notable population aging, with Germany's population aged 65 and older projected to increase by 41% to 24 million by 2050. Additionally, 19% of the UK population was already over 65 in 2022, leading to higher demand for diagnostic and minimally invasive procedures. The growing burden of chronic diseases and cancer also drives the need for disposable endoscopes, with 53.7% of adults in Germany reporting chronic conditions in 2024, and cancer-related deaths reaching 138,579 in England (2022) and 230,292 in Germany (2023). Coupled with well-established hospitals, the adoption of advanced medical technology, and supportive regulatory frameworks, these factors together create a strong market environment, making Europe a key growth region in the global disposable endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 -40%, Tier 2 -30%, and Tier 3 -30%
• By Designation: C-level -50%, Director level -30%, and Others -20%
• By Region: North America -30%, Europe - 25%, Asia Pacific -20%, Latin America -15%, and Middle East & Africa -10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = > USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = < USD 1.0 billion

C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the disposable endoscopes market include Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), GI View Ltd (Isareal), Richard Wolf GmbH (Germany), Daichuan medica (China), Scivita Medical (China), Uroviu Corporation (US), Neoscope Inc. (US), Verathon Inc. A Ropper Technologies Company (US), Integrated Endoscopy (US), HUGER Medical Instrument Co., Ltd. (China), Guangzhou Red Pine Medical Instrument Co. Ltd. (China), Nanchang WOEK Medical Technology Co., Ltd (China), Innovex Medical Co., Ltd. (China), Xenocor (US), MacroLux Medical Technology Co., Ltd. (China), THE COOPER COMPANIES, INC. (US), Shenzhen HugeMed Medical Technical Development Co., Ltd. (China), and Xi'an Haiye Medical Equipment Co., Ltd. (China).

Research Coverage

This report examines the disposable endoscopes market based on type, application, clinical use, end user, and region. It also explores factors such as drivers, restraints, opportunities, and challenges influencing market growth, and provides an overview of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their individual growth trends and forecasts the revenue of market segments across five major regions and their respective countries.

Reasons to Buy the Report

The report will help both established and smaller firms understand the market, which, in turn, will assist them in increasing their market share. Firms purchasing the report can use one or a combination of the strategies mentioned below to strengthen their position in the market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (Increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (High overhead costs of endoscopy procedures), opportunities (Rapidly developing healthcare sector in emerging countries), challenges (Environmental concerns related to medical waste disposal, limited reimbursement policies)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the disposable endoscopes market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the disposable endoscopes market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the disposable endoscopes industry help to diversify the market
• Competitive Assessment: In-depth assessment of market share, growth strategies and product offerings of leading players like Olympus Corporation (Japan), Boston Scientific Corporation (US), HOYA Corporation (Japan), Ambu A/s (Denmark), Karl Storz SE & Co. KG (Germany), Hunan Vathin Medical Instrument Co., Ltd. (China), Zhuhai Pusen Medical Technology Co., Ltd. (China), and among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 DISPOSABLE ENDOSCOPES MARKET OVERVIEW
• 3.2 NORTH AMERICA: DISPOSABLE ENDOSCOPES MARKET, BY END USER
• 3.3 GEOGRAPHIC SNAPSHOT OF DISPOSABLE ENDOSCOPES MARKET (2024)
• 3.4 GEOGRAPHIC MIX: DISPOSABLE ENDOSCOPES MARKET, 2025-2030 (USD MILLION)
• 3.5 DISPOSABLE ENDOSCOPES MARKET: DEVELOPING VS. DEVELOPED MARKETS

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Growing demand for infection control and regulatory push
    • 4.2.1.2 Rising burden of chronic diseases
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Environmental impact and sustainability concerns
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Rapidly developing healthcare sector in emerging economies
  • 4.2.4 CHALLENGES
    • 4.2.4.1 High upfront expenditure per procedure
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN DISPOSABLE ENDOSCOPES MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNTIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNTIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL ENDOSCOPY EQUIPMENT IDUSTRY
  • 5.2.4 TRENDS IN GLOBAL FLEXIBLE ENDOSCOPES INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY KEY PLAYER (2022-2024)
  • 5.6.2 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY TYPE (2022-2024)
  • 5.6.3 AVERAGE SELLING PRICE TREND OF DISPOSABLE ENDOSCOPES, BY REGION (2022-2024)
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT SCENARIO (HS CODE 9018)
  • 5.7.2 EXPORT DATA (HS CODE 9018)
• 5.8 KEY CONFERENCES & EVENTS, 2025-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 CASE STUDY 1: ICU BRONCHOSCOPY PERFORMANCE AND ADOPTION
  • 5.11.2 CASE STUDY 2: ERCP INFECTION-CONTROL CONVERSION PATHWAY
  • 5.11.3 CASE STUDY 3: OPTIMIZING TRANSBRONCHIAL CRYOBIOPSY IN INTERSTITIAL LUNG DISEASE USING AMBU ASCOPE 5 BRONCHO HD
• 5.12 IMPACT OF 2025 US TARIFFS ON DISPOSABLE ENDOSCOPES MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRIES/REGIONS
    • 5.12.4.1 North America
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
  • 5.12.5 END-USE INDUSTRY IMPACT

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 CMOS & CCD IMAGING SENSORS
  • 6.1.2 FIBER-OPTIC ILLUMINATION SYSTEMS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 AI-ASSISTED IMAGE PROCESSING AND VISUALIZATION
• 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3.1 SHORT TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.3.2 MID TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 6.3.3 LONG TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 6.4 PATENT ANALYSIS
  • 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.5 FUTURE APPLICATIONS
  • 6.5.1 AI-ENABLED VISUALIZATION AND DIAGNOSTIC SUPPORT
  • 6.5.2 BIODEGRADABLE & ECO-FRIENDLY ENDOSCOPES
  • 6.5.3 SMART ENDOSCOPES WITH EMBEDDED SENSORS
• 6.6 IMPACT OF AI/GEN AI ON DISPOSABLE ENDOSCOPES MARKET
  • 6.6.1 TOP USE CASES & MARKET POTENTIAL
• 6.7 BEST PRACTICES IN DISPOSABLE ENDOSCOPES PROCESSING
  • 6.7.1 CASE STUDIES OF AI IMPLEMENTATION IN DISPOSABLE ENDOSCOPES MARKET
  • 6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
  • 6.7.3 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN DISPOSABLE ENDOSCOPES MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF DISPOSABLE ENDOSCOPES
    • 7.2.1.1 Carbon impact reduction
    • 7.2.1.2 Eco-applications
• 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
• 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 KEY BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 DISPOSABLE ENDOSCOPES MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 UROLOGY ENDOSCOPES
  • 9.2.1 UROLOGY ENDOSCOPES SEGMENT TO HOLD MAJOR SHARE OF MARKET
• 9.3 BRONCHOSCOPES
  • 9.3.1 RISING PREVALENCE OF LUNG CANCER TO BOOST SEGMENTAL GROWTH
• 9.4 CYSTOSCOPES
  • 9.4.1 GROWING BURDEN OF BLADDER CANCER TO AID SEGMENTAL GROWTH
• 9.5 GI ENDOSCOPES
  • 9.5.1 STRINGENT REGULATORY RECOMMENDATIONS FROM US FDA TO ACCELERATE SHIFT TOWARD SINGLE-USE GI ENDOSCOPES
• 9.6 LARYNGOSCOPES
  • 9.6.1 RISING INFECTION CONTROL AND INCREASING LARYNGEAL DISORDER BURDEN TO DRIVE SEGMENTAL GROWTH
• 9.7 ARTHROSCOPES
  • 9.7.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
• 9.8 OTHER DISPOSABLE ENDOSCOPES

10 DISPOSABLE ENDOSCOPES MARKET, BY CLINICAL USAGE

• 10.1 INTRODUCTION
• 10.2 SURGICAL USAGE
  • 10.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
• 10.3 DIAGNOSTIC USAGE
  • 10.3.1 RISING PREFERENCE FOR SAFE AND EFFICIENT DIAGNOSTIC PROCEDURES TO DRIVE ADOPTION OF DISPOSABLE ENDOSCOPES

11 DISPOSABLE ENDOSCOPES MARKET, BY APPLICATION

• 11.1 INTRODUCTION
• 11.2 UROLOGY
  • 11.2.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO AID MARKET GROWTH
• 11.3 BRONCHOSCOPY
  • 11.3.1 RISING INFECTION CONTROL NEEDS TO DRIVE GROWTH OF BRONCHOSCOPY SEGMENT
• 11.4 GASTROENTEROLOGY
  • 11.4.1 TECHNOLOGICAL ADVANCEMENTS AND GROWING PROCEDURAL VOLUMES IN HOSPITAL ENDOSCOPY UNITS TO FUEL DEMAND
• 11.5 ENT
  • 11.5.1 ABILITY OF DISPOSABLE ENT ENDOSCOPES TO REDUCE CROSS-CONTAMINATION RISKS TO DRIVE DEMAND
• 11.6 OTHER APPLICATIONS

12 DISPOSABLE ENDOSCOPES MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 HOSPITALS
  • 12.2.1 HOSPITALS TO DOMINATE DISPOSABLE ENDOSCOPES MARKET DURING FORECAST PERIOD
• 12.3 AMBULATORY SURGERY CENTERS
  • 12.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO ACCELERATE GROWTH
• 12.4 CLINICS
  • 12.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND MINOR PROCEDURES TO DRIVE SEGMENTAL GROWTH
• 12.5 OTHER END USERS

13 DISPOSABLE ENDOSCOPES MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 US to dominate North American disposable endoscopes market during forecast period
  • 13.2.3 CANADA
    • 13.2.3.1 Stringent infection control standards and rising chronic disease burden to adoption of disposable endoscopes
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 GERMANY
    • 13.3.2.1 Germany to dominate European disposable endoscopes market
  • 13.3.3 UK
    • 13.3.3.1 Growing aging population and infection control focus to boost market
  • 13.3.4 FRANCE
    • 13.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
  • 13.3.5 ITALY
    • 13.3.5.1 Increasing aging population and prevalence of chronic diseases to boost adoption of disposable endoscopes
  • 13.3.6 SPAIN
    • 13.3.6.1 Rising aging population to drive market growth
  • 13.3.7 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 China to account for largest share of APAC region in disposable endoscopes market
  • 13.4.3 JAPAN
    • 13.4.3.1 Increasing chronic diseases and geriatric population to drive Japan's growth in market
  • 13.4.4 INDIA
    • 13.4.4.1 Rising disease burden and aging population to position India as key growth hub in Asia Pacific
  • 13.4.5 AUSTRALIA
    • 13.4.5.1 Rising cancer burden and expanding screening programs to support disposable endoscopes adoption in Australia
  • 13.4.6 SOUTH KOREA
    • 13.4.6.1 Robust cancer screening programs to drive strong adoption of disposable endoscopes
  • 13.4.7 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 BRAZIL
    • 13.5.2.1 Brazil to account for largest share of LATAM market in 2024
  • 13.5.3 MEXICO
    • 13.5.3.1 Expanding healthcare infrastructure to strengthen Mexico's position in global market
  • 13.5.4 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Increasing healthcare investments and hospital expansions to drive market growth
  • 13.6.3 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DISPOSABLE ENDOSCOPES MARKET
• 14.3 REVENUE ANALYSIS, 2020-2024
• 14.4 MARKET SHARE ANALYSIS, 2024
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Region footprint
    • 14.5.5.3 Type footprint
    • 14.5.5.4 Application footprint
    • 14.5.5.5 End-user footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 14.6.5.1 Detailed list of key startups/SMEs
    • 14.6.5.2 Competitive benchmarking of key startups/SMEs
• 14.7 COMPANY VALUATION & FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/PRODUCT COMPARISON
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES & APPROVALS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 AMBU A/S
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product launches & approvals
      • 15.1.1.3.2 Expansions
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses & competitive threats
  • 15.1.2 BOSTON SCIENTIFIC CORPORATION
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product approvals
      • 15.1.2.3.2 Deals
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses & competitive threats
  • 15.1.3 OLYMPUS CORPORATION
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Product approvals
      • 15.1.3.3.2 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses & competitive threats
  • 15.1.4 HOYA CORPORATION
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Deals
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses & competitive threats
  • 15.1.5 VERATHON INC.
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses & competitive threats
  • 15.1.6 KARL STORZ SE & CO. KG
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Product launches
      • 15.1.6.3.2 Deals
  • 15.1.7 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Deals
  • 15.1.8 INNOVEX MEDICAL CO., LTD.
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products offered
  • 15.1.9 SCIVITA MEDICAL
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products offered
  • 15.1.10 GUANGZHOU RED PINE MEDICAL INSTRUMENT CO., LTD.
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products offered
• 15.2 OTHER PLAYERS
  • 15.2.1 THE COOPER COMPANIES, INC.
  • 15.2.2 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.
  • 15.2.3 UROVIU CORPORATION
  • 15.2.4 OTU MEDICAL
  • 15.2.5 GI VIEW LTD.
  • 15.2.6 TSC LIFE
  • 15.2.7 RICHARD WOLF GMBH
  • 15.2.8 DAICHUAN MEDICA
  • 15.2.9 NEOSCOPE INC.
  • 15.2.10 INTEGRATED ENDOSCOPY
  • 15.2.11 HUGER MEDICAL INSTRUMENT CO., LTD.
  • 15.2.12 XENOCOR
  • 15.2.13 MACROLUX MEDICAL TECHNOLOGY CO., LTD.
  • 15.2.14 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO., LTD.
  • 15.2.15 ZHEJIANG GEYI MEDICAL DEVICES CO., LTD.

16 RESEARCH METHODOLOGY

• 16.1 RESEARCH DATA
  • 16.1.1 SECONDARY DATA
    • 16.1.1.1 Key data from secondary sources
  • 16.1.2 PRIMARY DATA
    • 16.1.2.1 Key data from primary sources
    • 16.1.2.2 Key industry insights
• 16.2 MARKET SIZE ESTIMATION
• 16.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 16.4 MARKET RANKING ANALYSIS
• 16.5 STUDY ASSUMPTIONS
• 16.6 RESEARCH LIMITATIONS
  • 16.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 16.6.2 SCOPE-RELATED LIMITATIONS
• 16.7 RISK ASSESSMENT

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS